Jun Y.

Jun Y. has a diverse work experience starting from 1999 working as a research assistant at The Scripps Research Institute. They then held various roles in business development and finance in companies such as Syrrx, MemRx Corporation, and Sagres Discovery. Jun also served as the Sr. Director of Licensing & Business Development at VIA Pharmaceuticals and later as the Vice President of Corporate Development at Cellerant Therapeutics. In 2016, they became an independent consultant in the biotechnology and life sciences field. Jun also co-founded Structure Therapeutics in 2016 and served as the Chief Operating Officer before becoming the Chief Financial Officer in 2022. Jun was also a board member at The GPCR Consortium. Overall, Jun Y. has a strong background in finance, business development, and management within the biotechnology industry.

Jun Y. holds a Bachelor's Degree in Molecular Cell Biology from the University of California, Berkeley.